GlycoMar is currently developing a range of glycosaminoglycans from marine invertebrates. These are being evaluated for a number of applications, including anti-inflammatory drug discovery.
Glycoproteins
GlycoMar is currently developing a group of mucin-type glycoproteins from marine invertebrates. These are being evaluated as anti-inflammatories.
Enzymes
GlycoMar is developing diagnostic enzymes from marine bacteria and marine invertebrates.
